Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab

Boku, N; Satoh, T; Ryu, MH; Chao, Y; Kato, K; Chung, HC; Chen, JS; Muro, K; Kang, WK; Yeh, KH; Yoshikawa, T; Oh, SC; Bai, LY; Tamura, T; Lee, KW; Hamamoto, Y; Kim, JG; Chin, K; Oh, DY; Minashi, K; Cho, JY; Tsuda, M; Nishiyama, T; Chen, LT; Kang, YK

Boku, N (corresponding author), Natl Canc Ctr, Div Gastrointestinal Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.

GASTRIC CANCER, ; ():

Abstract

Background ATTRACTION-2 demonstrated that nivolumab improved overall survival (OS) vs placebo in patients with advanced gastric cancer treated with &g......

Full Text Link